How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,907 results for

Hip Injection

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

201. Nonarthritic Hip Disease Evaluation And Treatment

Pattern Training No Intervention: 3-week Wait Period Participants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time. Observational Arm Participants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed (...) Nonarthritic Hip Disease Evaluation And Treatment Nonarthritic Hip Disease Evaluation And Treatment - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Nonarthritic Hip Disease Evaluation And Treatment (NEAT

2018 Clinical Trials

202. A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis

(Kellgren and Lawrence X-ray stage ≥ 2) Mean pain VAS on at least one reference joint (knee or hip)> 40 mm during the last week Stable treatment with analgesics for at least a week Exclusion Criteria: Corticosteroids (oral or injectable) in the month prior to inclusion Intra-articular injection of hyaluronic acid in the last 3 months prior to inclusion Inflammatory rheumatic disease (rheumatoid arthritis, spondyloarthritis, CCPD) Current depressive episode Psychotic disorders Usual practice (...) A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2018 Clinical Trials

203. Range of Motion, Muscular Strength and Functionality of Patients Submitted to Total Hip Arthroplasty.

system in the physiotherapy sector of reference hospitals; who read and consent to the Informed Consent Form and understood the orientations necessary for the evaluation proposed in this study. Exclusion Criteria: Performing a surgical procedure on other joints in the lower limbs; previous surgical procedures in the hip joint; osteoarticular diseases in lower limb joints; presence of signs or symptoms of contralateral hip osteoarthrosis; performed intra-articular injection of corticosteroids (...) Range of Motion, Muscular Strength and Functionality of Patients Submitted to Total Hip Arthroplasty. Range of Motion, Muscular Strength and Functionality of Patients Submitted to Total Hip Arthroplasty. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2018 Clinical Trials

204. Fascia Iliaca Blocks for Total Hip Arthroplasty

in Unilateral Direct Anterior Approach Total Hip Arthroplasty Actual Study Start Date : May 15, 2018 Estimated Primary Completion Date : December 31, 2018 Estimated Study Completion Date : March 31, 2019 Resource links provided by the National Library of Medicine available for: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Low dosis bupivacaine Preoperative fascia iliaca block with Marcaine 0.25% (0.11 mL x subject height) Drug: Marcaine 0.25 % Injectable Solution Fascia iliaca (...) Fascia Iliaca Blocks for Total Hip Arthroplasty Fascia Iliaca Blocks for Total Hip Arthroplasty - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Fascia Iliaca Blocks for Total Hip Arthroplasty The safety

2018 Clinical Trials

205. Hip Arthroplasty by Direct Anterior Approach Using Minimally Invasive Surgery & Anesthesia

Hip Arthroplasty by Direct Anterior Approach Using Minimally Invasive Surgery & Anesthesia Hip Arthroplasty by Direct Anterior Approach Using Minimally Invasive Surgery & Anesthesia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Hip Arthroplasty by Direct Anterior Approach Using Minimally Invasive Surgery & Anesthesia The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03663426 Recruitment Status : Not yet recruiting First

2018 Clinical Trials

206. Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty. Full Text available with Trip Pro

model, because of the high regenerative and immunomodulatory potency of this cell type.Our pilot phase I/IIa study was prospective, randomized, double blind, and placebo-controlled. Twenty patients undergoing hip arthroplasty via a direct lateral approach received an injection of 3.0 × 108 (300 M, n = 6) or 1.5 × 108 (150 M, n = 7) PLX-PAD or a placebo (n = 7) into the injured gluteus medius muscles.We did not observe any relevant PLX-PAD-related adverse events at the 2-year follow-up. Improved (...) Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty. No regenerative approach has thus far been shown to be effective in skeletal muscle injuries, despite their high frequency and associated functional deficits. We sought to address surgical trauma-related muscle injuries using local intraoperative application of allogeneic placenta-derived, mesenchymal-like adherent cells (PLX-PAD), using hip arthroplasty as a standardized injury

2018 Journal of cachexia, sarcopenia and muscle Controlled trial quality: predicted high

207. Traumatic Obturator Hip Dislocation with Marginal Femoral Head Fracture in a 15-Year-Old Adolescent: A High-Energy Trauma—A Case Report and a Review of the Literature Full Text available with Trip Pro

showed an avascular femoral head necrosis, for which we performed multiple retrograde femoral head drilling, completed by the injection of autologue stem cells from the iliaq crest. One year later, the patient has no hip pain, no joint limitation, and can practice BMX at a high level again. The purpose of this report is to make the physicians aware of this rare problem that may be damaging for hip function, especially in young people. (...) Traumatic Obturator Hip Dislocation with Marginal Femoral Head Fracture in a 15-Year-Old Adolescent: A High-Energy Trauma—A Case Report and a Review of the Literature We report the case of a 15-year-old boy brought to the emergency department after a bike accident, complaining of an isolated left hip pain. The X-rays showed an obturator hip dislocation treated by closed reduction under general anaesthesia, followed by 6 weeks of discharge. The follow-up MRI performed 6 weeks after the trauma

2018 Case reports in orthopedics

208. Silicone-Induced Foreign Body Reaction: An Unusual Differential Diagnosis of Posterolateral Hip Pain Full Text available with Trip Pro

Silicone-Induced Foreign Body Reaction: An Unusual Differential Diagnosis of Posterolateral Hip Pain Silicone injection is commonly used for soft tissue augmentation for esthetic purposes. It is not without complications.We present a case of a 31-year-old woman presenting with refractory left lateral hip pain. Magnetic resonance imaging of the patient's pelvis revealed innumerable small low signal foci throughout the gluteus maximus and overlying subcutaneous fat bilaterally consistent (...) with injectable material, possibly silicone.This case report emphasizes that silicone-induced granulomatosis must be considered in the differential diagnosis of hip pain when evaluating a patient who has had access to plastic surgery or clandestine operators.

2018 Case reports in medicine

209. Ultrasound-guided continuous fascia iliaca compartment block for pre-operative pain control in very elderly patients with hip fracture: A randomized controlled trial Full Text available with Trip Pro

Ultrasound-guided continuous fascia iliaca compartment block for pre-operative pain control in very elderly patients with hip fracture: A randomized controlled trial The present study presented the results of a prospective, randomized controlled trial. The present study enrolled 98 very elderly patients with hip fractures, complicated with at least one cardiovascular, neurological or pulmonary disease, of whom 10 patients were excluded. A total of 88 patients were randomly assigned into 2 (...) groups: i) The control group, receiving traditional analgesia including 50 mg Tramadol and 500 mg paracetamol orally three times a day from admission to surgery; and ii) the study group, receiving ultrasound-guided continuous fascia iliaca compartment block (CFICB), a single 50 ml 0.4% ropivacaine injection with continuous infusion of 0.2% ropivacaine at a dose of 5 ml/h from admission to surgery. The primary outcome measure of pain relief or pain intensity was assessed preoperatively and up to 48 h

2018 Experimental and therapeutic medicine Controlled trial quality: uncertain

210. Extracapsular local infiltration analgesia in hip arthroscopy patients: a randomized, prospective study Full Text available with Trip Pro

. A prospective randomized controlled trial of 74 patients who underwent hip arthroscopy at a single medical center was performed. Thirty-seven patients received a 20-ml extracapsular injection of 0.25% bupivacaine-epinephrine under direct arthroscopic visualization after capsular closure while 37 from the control group received no injection. Primary outcome measures were both maximum and discharge numeric rating scale (NRS) pain scores while in the post-anesthesia care unit (PACU). The LIA group had (...) Extracapsular local infiltration analgesia in hip arthroscopy patients: a randomized, prospective study Hip arthroscopy patients can experience significant post-operative pain. Many strategies to combat this pain have been explored including nerve blocks, which can be costly. An alternative option for pain management is local infiltration analgesia (LIA) which has been studied in hip and knee arthroplasty, but its ability to decrease pain in the setting of hip arthroscopy remains uncertain

2018 Journal of hip preservation surgery Controlled trial quality: uncertain

211. Safety Profile and Short-term Outcomes of BST-CarGel as an Adjunct to Microfracture for the Treatment of Chondral Lesions of the Hip Full Text available with Trip Pro

Safety Profile and Short-term Outcomes of BST-CarGel as an Adjunct to Microfracture for the Treatment of Chondral Lesions of the Hip Acetabular cartilage lesions are a common abnormality found in patients undergoing hip arthroscopic surgery and may cause pain and functional limitations. Several strategies have been developed to treat chondral defects, with no overwhelming success. Recently, BST-CarGel has gained interest as a scaffolding material that can be injected into the microfracture site (...) to stabilize the clot and facilitate cartilage repair.To perform a retrospective analysis of prospectively collected data to evaluate the safety profile and short-term clinical and radiographic outcomes of patients treated arthroscopically with BST-CarGel for acetabular chondral defects in conjunction with microfracture.Case series; Level of evidence, 4.A retrospective chart review was performed on all patients who underwent hip arthroscopic surgery by the senior surgeon to identify those who had BST

2018 Orthopaedic journal of sports medicine

212. Rivaroxaban versus nadroparin for preventing deep venous thrombosis after total hip arthroplasty following femoral neck fractures: A retrospective comparative study Full Text available with Trip Pro

Rivaroxaban versus nadroparin for preventing deep venous thrombosis after total hip arthroplasty following femoral neck fractures: A retrospective comparative study Objective This study was performed to evaluate the efficacy of rivaroxaban versus nadroparin for preventing deep venous thrombosis (DVT) in elderly patients with osteoporosis undergoing initial total hip arthroplasty (THA) for femoral neck fractures. Methods Prospectively maintained databases were reviewed to retrospectively compare (...) elderly patients with osteoporosis who underwent initial THA for femoral neck fractures from 2007 to 2015. The patients received peroral rivaroxaban at 10 mg/day for 2 weeks or subcutaneous injections of nadroparin at 0.3 mL/day for 2 weeks until the primary analysis cut-off date. The time to first on-study DVT was the primary endpoint. Results In total, 399 patients were included (rivaroxaban group: n=200; mean age, 70.20 ± 9.16 years and nadroparin group: n = 199; mean age, 69.90 ± 8.87 years

2018 The Journal of international medical research

213. Single-dose lidocaine spinal anesthesia in hip and knee arthroplasty Full Text available with Trip Pro

the safety and efficacy of single-dose lidocaine spinal anesthesia in the setting of outpatient joint arthroplasty.We performed a prospective study on 50 patients who received lidocaine spinal anesthesia in the setting of outpatient hip and knee arthroplasty. All patients received a single-shot spinal injection, with 2% isobaric lidocaine along with titrated propofol sedation. We evaluated demographic data, length of motor blockage, time to ambulation, time to discharge readiness, patient-reported (...) spinal anesthesia appears to be a safe and effective regimen for outpatient hip and knee arthroplasty. All patients were discharged on the day of surgery with isobaric lidocaine spinal injection. There were no reports of TNSs.

2018 Arthroplasty today

214. Infiltration Techniques for Local Infiltration Analgesia With Liposomal Bupivacaine in Extracapsular and Intracapsular Hip Fracture Surgery: Expert Panel Opinion. (Abstract)

Infiltration Techniques for Local Infiltration Analgesia With Liposomal Bupivacaine in Extracapsular and Intracapsular Hip Fracture Surgery: Expert Panel Opinion. Liposomal bupivacaine (LB) has demonstrated efficacy in improving pain scores and reducing opioid consumption across a variety of surgical settings, including orthopaedic surgery. However, meticulous infiltration techniques combined with a multimodal approach are important to optimizing outcomes.A panel of 4 orthopaedic surgeons and 3 (...) anesthesiologists convened on April 1, 2017, to discuss current practices and develop a consensus statement regarding local infiltration analgesia with LB for extracapsular and intracapsular hip fracture surgery, including LB infiltration techniques.Optimizing surgical outcomes with LB in hip fracture surgery requires an understanding of the neuroanatomy of the surgical site and the pharmacology of the drug. Meticulous infiltration technique is critical to achieve optimal results with LB given its viscosity

2018 Journal of Orthopaedic Trauma

215. Prolonged vasopressor support during hip-fracture surgery is a risk factor for enhanced mortality. (Abstract)

were 6.7%, 10.3%, 11.6% and 30.3% respectively. Finally, the same patient groups had 365-day mortality rates of 12.8%, 20.0%, 23.3% and 44.9% respectively. We found a significant increase in mortality (30-90-365 days) in patients receiving VP infusion ≥3 hours, after adjusting for confounding factors. There was no increased mortality in patients treated by injection and by infusion <3 hours after adjustment for confounding factors vs untreated patients.Vasopressor treatment is common during hip (...) Prolonged vasopressor support during hip-fracture surgery is a risk factor for enhanced mortality. Hip fracture is a common injury in the elderly population and is associated with high morbidity and mortality. Intraoperative hypotension is commonly noted, and is often treated with vasopressors (VP), however, to what extent is unknown. We set out to examine retrospectively how many hip fracture-patients received VP perioperatively and further to investigate if VP treatment is connected

2018 Acta Anaesthesiologica Scandinavica

216. Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement

Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03744065 Recruitment Status : Recruiting First Posted : November 16, 2018 Last Update Posted

2018 Clinical Trials

217. Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study. Full Text available with Trip Pro

Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study. Randomized trials have shown the benefits of injecting bone marrow-derived mesenchymal stem cells (BmMSCs) after standard hip decompression in patients with osteonecrosis of the femoral head. However, the combination of BmMSCs and platelet-rich plasma (PRP) injected into the femoral head after decompression has not been reported previously. This study reports (...) % CI, 55%-79%), and 93% (95% CI, 76%-98%), respectively, at 3 years postoperatively; two patients (four hips) underwent a second decompression and MSC injection for persistent pain without signs of radiographic collapse. All patients with collapse underwent THA. The mean modified Kerboul angle improved from 205° ± 47° to 172° ± 48° postoperatively (mean change -30° ± 6°, p = 0.01). A greater proportion of patients who underwent an additional procedure had a modified Kerboul grade of 3 or 4

2018 Clinical Orthopaedics and Related Research

218. Unusual indication of Cell therapy for hip osteonecrosis after pregnancy Full Text available with Trip Pro

(MSC) injection obtained from bone marrow concentration. The average total number of MSCs (counted as number of colonies forming units-fibroblast) injected in the hip was 185 000 ± 65 000 cells (range 95 000-240 000 cells).At the most recent follow-up (average 15 years after hip surgery, range 8-25 years), among the 145 hips included in the study, 4 hips (2.7%) had collapsed and were treated with total hip arthroplasty (THA). Thirty-two of the 94 stage I had progressed to stage II; and 4 of the 51 (...) Unusual indication of Cell therapy for hip osteonecrosis after pregnancy Osteonecrosis is a rare event during or after pregnancy. Due to the low number of cases, there is no report of long-term results after conservative surgery in this population.From 1992 to 2010, 145 consecutive female patients with unilateral symptomatic (94 stage I and 51 stage II) left hip osteonecrosis (ON) related to pregnancy were treated between 4 and 16 months after delivery with percutaneous mesenchymal stem cell

2018 SICOT-J

219. SCP Hip Outcomes Study

Estimated Enrollment : 100 participants Observational Model: Cohort Time Perspective: Other Official Title: A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Hip Actual Study Start Date : March 27, 2018 Estimated Primary Completion Date : March 2022 Estimated Study Completion Date : March 2025 Groups and Cohorts Go to Intervention Details: Device: Subchondroplasty Procedure with AccuFill Injection of the commercially available flowable calcium phosphate (CaP) synthetic bone-void (...) SCP Hip Outcomes Study SCP Hip Outcomes Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. SCP Hip Outcomes Study The safety and scientific validity of this study is the responsibility of the study

2018 Clinical Trials

220. Peri-operative Vasopressor Support in Patients Operated for an Acute Hip Fracture (AHF)

with an acute hip fracture (AHF) noting confounding factors and the usage of vasopressors either by injections or infusions and then correlated these results to mortality at 30-, 90- and 365- days Condition or disease Hip Fractures Intraoperative Hypotension Detailed Description: The incidence of hypotension perioperatively during operation of an acute hip fracture is unknown. As a surrogate factor the usage of vasopressor support is more adequate as the registration of vasopressor drugs are many times (...) not complete in records. The investigators retrospectively investigated the anesthetic journals of 1100 patients with an acute hip fracture (AHF) noting confounding factors and the usage of vasopressors either by injections or infusions and then correlated these results to mortality at 30-, 90- and 365-days Confounding factors were; all comorbitity, age, ASA grade as well as type of anesthesia Study Design Go to Layout table for study information Study Type : Observational Actual Enrollment : 997

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>